Protagonist Therapeutics (PTGX) Current Deferred Revenue (2017 - 2026)
Protagonist Therapeutics (PTGX) recorded Current Deferred Revenue of $9.66 million in Q2 2026, down 34.2% from $14.69 million a year earlier but up 53.8% from the prior quarter.
Powered by 
Analysis
Protagonist Therapeutics (PTGX) Current Deferred Revenue (2017 - 2026) Analysis & Trends
At the end of FY2025, Protagonist Therapeutics reported Current Deferred Revenue of $9.55 million, down 49.4% from FY2024.
- Annual Current Deferred Revenue has a five-year compound annual growth rate of -8.0% (FY2020 to FY2025).
- Across earlier years, Current Deferred Revenue came in at $18.89 million in FY2024, $3,000 in FY2023 (-95.7%), $69,000 in FY2022 (-92.3%) and $899,000 in FY2021 (-93.8%).
- Quarterly Current Deferred Revenue has ranged from $3,000 in Q3 2023 to $20.12 million in Q2 2024 over the past five years.
- On a year-over-year basis, Current Deferred Revenue has declined for five consecutive quarters, with an average decline of 32.8% over the last six quarters.
- Peak year-over-year performance for Current Deferred Revenue in the last five years was growth of 4.8% in Q1 2025, against a decline of 98.6% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.28 million (Q1 2026), $9.55 million (Q4 2025) and $14.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Protagonist Therapeutics | 9.11 Bn | 9.11 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.66 Mn |
| Mar 31, 2026 | 6.28 Mn |
| Dec 31, 2025 | 9.55 Mn |
| Sep 30, 2025 | 14.20 Mn |
| Jun 30, 2025 | 14.69 Mn |
| Mar 31, 2025 | 16.90 Mn |
| Dec 31, 2024 | 18.89 Mn |
| Sep 30, 2024 | 19.70 Mn |
| Jun 30, 2024 | 20.12 Mn |
| Mar 31, 2024 | 16.13 Mn |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Dec 31, 2022 | 69,000.00 |
| Sep 30, 2022 | 32,000.00 |
| Mar 31, 2022 | 768,000.00 |
| Dec 31, 2021 | 899,000.00 |
| Sep 30, 2021 | 2.24 Mn |
| Jun 30, 2021 | 2.01 Mn |
| Mar 31, 2021 | 5.77 Mn |
| Dec 31, 2020 | 14.48 Mn |
API Access
Protagonist Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PTGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "PTGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PTGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();